China Biopharma Podcast: Interview with AZ, Sciwind’s Ecnoglutide Results and China Law Firm On BIOSECURE

Dexter Yan talks about his September interview with Sharon Barr, AstraZeneca’s executive vice president, Biopharmaceuticals R&D. Hu Xu shares her articles on Sciwind’s ecnoglutide Phase III results and a Chinese law firm’s view on the proposed US BIOSECURE Act.

Chinese biotech podcast
Join Dexter Yan and Xu Hu in the latest China biotech podcast • Source: Citeline/Shutterstock
Xu Hu

Read more by Xu Hu

Xu is a senior reporter and covers aspects on policy and regulations in China pharma industry within the APAC Pharma news team.

More from Podcasts

More from Scrip